Business
Bayer to Sell Diagnostics Division to Siemens for $5.3 Billion
Following on the heels of its successful takeover of drug company Schering AG, the Bayer Group has taken a move that will enable still more concentration on pharmaceuticals by announcing plans to sell its diagnostics division to Siemens AG for about U.S.$5.3 billion. More...30 Nov -0001
In Other News
Covance Expands Diagnostic Products and Services
BD Biosciences and Dynomics in Biomarker Alliance
Diagnostic Products/Testing Services Licensed to Gentris
New Company to Promote Use of Cardiac PET
Rogan-Delft Partners with Chinese Company for PACS Distribution
Chicago to Host AACC Meeting
Alliance to Develop Infectious Disease Diagnostics
Collaboration to Develop Molecular Tests for Skin Diseases
Varian Expands Presence in China
Siemens Signs IT Agreement with U.S. Health System
Biophan and Siemens to Design New MRI Systems
Biodesign Institute Named Lab of the Year
Siemens to Offer Digital Detection System
Philips to Acquire Cath Lab Company
Paris to Host Forum LABO
SPECT Software Licensed to Siemens
Dade Behring Receives Customer Service Award
Full-Service Contracts Drive European Imaging Market
Consulting Services for European Hospitals
Commercializing Protein Tomography Solutions
Radiotherapy Advances Presented at Research Summit
DJ Orthopedics to Acquire Brace Maker
Kodak Wins Customer Service Award
HospiMedica Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the healthcare industry worldwide.







